Searched for
LEQEMBI
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...- US Stocks: Apellis shares double on Biogen's $5.6 billion buyout planBiogen will buy Apellis Pharmaceuticals for about $5.6 billion, adding a promising kidney disease drug to broaden its rare-disease portfoli...
- Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatmentThe joint studies showed some improvement in a few biological measures of the disease, but most of the changes were small and not enough to...
- Novo Nordisk says Alzheimer's drug trial fails to meet main goalNovo Nordisk's Alzheimer's drug trials have ended without success. The semaglutide pill did not slow the brain disease's progression. This ...
- Alzheimer disease symptoms treatment: Can Alzheimer's be prevented? Doctors, health experts say yes, prescribe ways to check dementiaWhat makes people more at risk of getting Alzheimer's disease and dementia more broadly? Nearly half of all cases are linked to factors suc...
- US FDA approves world’s first blood test for Alzheimer’s, and what it meansThe FDA has approved the Lumipulse Plasma Ratio test, a groundbreaking blood test for early dementia detection. This less invasive alternat...
- US FDA clears first blood test to detect Alzheimer's diseaseThe FDA has cleared Fujirebio Diagnostics' Lumipulse blood test, marking the first of its kind for Alzheimer's diagnosis. This test measure...
- Trump tariffs on chips and drugs would hit U.S. allies in AsiaU.S. President Donald Trump plans to introduce tariffs on imported computer chips, pharmaceuticals, and steel to encourage domestic manufac...
- Blood tests for Alzheimer's may be coming to your doctor's office. Here's what to knowMore than 6 million people in the United States and millions more around the world have Alzheimer's, the most common form of dementia. Its ...
- New cancer-like rating system introduced for Alzheimer's diagnosisExperts have developed a new seven-point rating scale for diagnosing Alzheimer's disease based on cognitive and biological changes in patie...
- Here's a long-awaited new FDA-Approved treatment for Alzheimer's - Read moreThis could mark a new era for Alzheimer's treatment as the FDA grants full approval to a promising new drug called 'Lecanemab.' The drug is...
- Japan's Nikkei slumps for fourth straight session on Fed tightening concernsThe Nikkei has fallen 2.41% this week, after closing at a 33-year high on Monday. Since mid-March, it has rallied nearly 27%. After the ral...
- S&P 500 and Nasdaq close at highest since April 2022The S&P 500 and Nasdaq closed at their highest levels since April 2022, bolstered by gains in market heavyweights Amazon, Apple, and Tesla....
- Wall St climbs with focus on inflation data, Fed decisionWall Street indexes extended their recent rally as investors awaited inflation data and the Federal Reserve's interest rate decision. The L...
Load More
